Bird Global Q4 Sales $69.70M Beat $53.38M Estimate

Bird Global (NYSE:BRDS) reported quarterly sales of $69.70 million which beat the analyst consensus estimate of $53.38 million by 30.57 percent.

Bird Global (NYSE:BRDS) reported quarterly sales of $69.70 million which beat the analyst consensus estimate of $53.38 million by 30.57 percent.

Total
0
Shares
Related Posts
Read More

Annovis Bio Announces Statistically Significant Phase II/III Data In Patients With Early Alzheimer’s Disease; Efficacy In The CGIC Endpoint Was Not Reached Due To The Limited Number Of Patients And Short Trial Duration

Significantly higher rate of improvement in ADAS-Cog 11 scores in each treatment dose relative to placebo for patients with mild ADImprovement in cognition measured by ADAS-Cog 11 at three months is 3.3 points as

ANVS